Invitrogen™ LYVE1 Human ELISA Kit

Ref.: BL-RE-106374Manufacturer ref.: EHLYVE1X5 5 x 96 tests
€2,955.00 excl. VAT

Kit ELISA LYVE1 sandwich (human): quantitative determination of Hu LYVE1 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu LYVE1.

Accession number
Q9Y5Y7
Dose range
8.19 pg/ml to 2.000 pg/ml
Sensitivity of the dosage
8 pg/ml
Calibration range
8 pg/ml to 2000 pg/ml
Dose
ELISA solid-phase sandwich
Brand
Invitrogen

Kit ELISA LYVE1 sandwich (human): quantitative determination of Hu LYVE1 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu LYVE1.

Kit ELISA LYVE1 sandwich (human): quantitative determination of Hu LYVE1 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu LYVE1.

Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.

Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).

LYVE1 was identified as a major receptor for HA (hyaluronane, extracellular matrix glycosaminoglycan) on the lymphatic vessel wall. The amino acid sequence derived from LYVE1 predicted a 322-type full membrane polypeptide type I residues similar to the CD44 HA receptor with a 212-residue extracellular domain containing a single Link module, the prototypic HA binding domain of the Link protein superfamily. Like CD44, the LYVE1 molecule binds soluble HAs and immobilized HAs. However, unlike CD44, the LYVE1 molecule colocates with HA on the luminal side of the lymphatic vessel wall and is completely absent from the blood vessels. Therefore, LYVE1 is the first lymph specific HA receptor to be characterized and is a unique and powerful marker for the lymphatic vessels themselves. LYVE1 is a Type I integral membrane glycoprotein. LYVE-1 is primarily expressed on the endothelium of the lymphatic vessels and is likely to be involved in regulating the trafficking of leukocytes and tumour cells to the lymph nodes. Lymphatic vasculature forms a second circulatory system that drains extracellular fluid from tissues and provides an exclusive environment in which immune cells can meet and respond to foreign antigens. Several molecules were identified as markers for lymphatic lheendothelium that include LYVE1, PALE, VEGFR3 and podoplanin. Among the diseases associated with LYVE1 dysfunction, there is complete androgen insensitivity syndrome.

Sensitivity

Sensitivity of dosage: 8 pg/ml.

Measurement range

Dosing range: 8.19 pg/ml to 2.000 pg/ml.

Duration of dosing

Total dosage duration: 4 hours 45 min.

Target

Target: Human.

Samples

Sample type: Plasma, Serum, Surnatant (plasma volume, 1 μl; serum, 1 μl; supernatant, 100 μl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17185499
Specifications
Accession numberQ9Y5Y7
Dose range8.19 pg/ml to 2.000 pg/ml
Sensitivity of the dosage8 pg/ml
Calibration range8 pg/ml to 2000 pg/ml
DoseELISA solid-phase sandwich
ConjugateBiotin
Product typeKit ELISA
Protein familyCell structure & organic proteins
Type of samplePlasma, Serum, Surnatant
SpecificityThis ELISA kit shows no cross-reactivity with the following tested cytokines: human angiogenin, BDNF, BLC, ENA-78, FGF- 4, IL-1 alpha, IL-1 beta, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-11, IL-12 p70, IL-12 p40, IL-13, IL-15, IL-309, IP-10, G-CSF, GM-CSF, IFN-gamma, leptin (
Sufficient for5 x 96 dosages
Target speciesHuman
For use with (application)ELISA, protein dosage, protein biology, cancerology, immunology, neuroscience, neurobiology, protein detection, protein analyses
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)10894
Gene symbol(s)CRSBP-1,HAR,LYVE-1,XLKD1
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kits96-well pre-coated plates, Chromogen, Wash pad, Stop solution, Adhesive plate covers, Dosing diluent concentrate, SAV-HRP, Biotinylated detection antibody, Calibration
Marker or dyeHRP
Quantity5 x 96 tests
Regulatory statusRUO
Research disciplinesCellular cycle & proliferation
SynonymUNQ230/PRO263, CRSBP-1, HAR, LYVE-1, XLKD1
TargetHuman
Test time1 hour 20 minutes.
Physical characteristics
Volume of samplePlasma, 1 μl; serum, 1 μl; supernatant, 100 μl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4:45 a.m.

Origin and customs

Manufacturer ref.EHLYVE1X5
Country of originUnited States
A question or a specific configuration?
Contact us for a quote.